Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 23,444 | 13,438 | 13,602 | 16,247 | 21,481 |
| Operating Income | -23,444 | -13,438 | -13,602 | -16,247 | -21,481 |
| Interest Expense | 87 | 87 | 336 | 12 | 0 |
| Other Income | 66 | 231 | 38 | 24 | 45 |
| Pre-tax Income | -23,465 | -13,294 | -13,900 | -16,235 | -21,436 |
| Net Income Continuous | -23,465 | -13,294 | -13,900 | -16,235 | -21,436 |
| Net Income | $-23,465 | $-13,294 | $-13,900 | $-16,235 | $-21,436 |
| EPS Basic Total Ops | -0.41 | -0.39 | -0.38 | -0.49 | -0.76 |
| EPS Basic Continuous Ops | -0.41 | -0.25 | -0.35 | -0.46 | -0.73 |
| EPS Diluted Total Ops | -0.41 | -0.39 | -0.38 | -0.49 | -0.76 |
| EPS Diluted Continuous Ops | -0.41 | -0.25 | -0.35 | -0.46 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -0.41 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-23,408 | $-13,403 | $-13,602 | $-16,246 | $-21,474 |